Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 683 of 1,261
  1. US 9399666

    Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  2. US 9399056

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  3. CA 2970060

    COMBINAISON DE BENZYDAMINE ET D'UN ANTIFONGIQUE POUR LE TRAITEMENT DE LA MYCOSE

    ACRAF [IT] · Granted Jul 21, 2016 · Expires Jul 16, 2036

    granted
  4. US 2016206702

    PEGylated Recombinant Human Growth Hormone Compounds

    ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS [DK] · Granted Jul 21, 2016 · Expires Jul 16, 2036

    granted
  5. EP 3044215

    VERFAHREN ZUR HERSTELLUNG VON MEDIKAMENTEN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN UND DARIN VERWENDETE ZWISCHENPRODUKTE

    BIAL PORTELA & CA SA [PT] · Granted Jul 20, 2016 · Expires Jul 15, 2036

    granted
  6. US 9394323

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  7. US 9393245

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  8. US 9394540

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  9. US 9394275

    Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  10. US 9393351

    Cloned biological material medical device and method thereof

    FIRST PRINCIPLES, INC. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  11. US 9394359

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  12. US 9394302

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  13. US 9393203

    Osmotic drug delivery system

    Supernus Pharmaceuticals, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  14. US 9394269

    Process-scale synthesis of urolithins

    Amazentis SA · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  15. US 9394545

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  16. US 9395369

    Guinea pig cytomegalovirus (CIDMTR strain)

    Regents of the University of Minnesota · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  17. US 9394569

    Methods and kits for early detection of cancer or predisposition thereto

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  18. US 9394541

    Oral delivery of nucleic acid-based gene interfering agents by Salmonella

    The Regents of the University of California · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  19. US 9394369

    Luminescent porous silicon nanoparticles for targeted delivery and immunization

    The Regents of the University of California · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  20. US 9394364

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  21. US 9394531

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Biosciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  22. US 9394358

    Gene signature for predicting prognosis of patients with solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  23. US 9394352

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  24. US 9394329

    Glucopyranosyl derivatives and their uses in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.